U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Edoxaban (Lixiana) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

Cover of Edoxaban (Lixiana)

Edoxaban (Lixiana) [Internet].

Show details

APPENDIX 2LITERATURE SEARCH STRATEGY

OVERVIEW
Interface:Ovid
Databases:Embase 1974 to present
MEDLINE Daily and MEDLINE 1946 to present
MEDLINE In-Process & Other Non-Indexed Citations
Note: Subject headings have been customized for each database. Duplicates between databases were removed in Ovid.
Date of Search:October 7, 2016
Alerts:Weekly search updates until February 15, 2016
Study Types:No search filters were applied
Limits:No language or date limits
Human only
Conference abstracts were excluded
SYNTAX GUIDE
/At the end of a phrase, searches the phrase as a subject heading
.shAt the end of a phrase, searches the phrase as a subject heading
MeSHMedical Subject Heading
fsFloating subheading
expExplode a subject heading
*Before a word, indicates that the marked subject heading is a primary topic; or, after a word, a truncation symbol (wildcard) to retrieve plurals or varying endings
#Truncation symbol for one character
?Truncation symbol for one or no characters only
adjRequires words are adjacent to each other (in any order)
adj#Adjacency within # number of words (in any order)
.tiTitle
.abAbstract
.otOriginal title
.hwHeading word; usually includes subject headings and controlled vocabulary
.ptPublication type
.rnCAS registry number
.nmName of substance word
pmezOvid database code; MEDLINE In-Process & Other Non-Indexed Citations, MEDLINE Daily and Ovid MEDLINE 1946 to Present
oemezdOvid database code; Embase 1974 to present, updated daily
MULTI-DATABASE STRATEGY
#Searches
1(Edoxaban* or Lixiana* or Savaysa* or DU 176* or DU176* or 32W99UE810 or UNII32W99UE810 or 606P02282F or UNII606P02282F or NDU3J18APO or UNIINDU3J18APO or 972203R4EW or UNII972203R4EW).ti,ab,kf,kw,ot,hw,rn,nm.
2(480448 29 1 or “480448291” or 48044829 1 or 48044829 1 or “0480448291” or 480449 70 5 or 48044970 5 or “480449705” or 480449 705 or 480449 71 6 or “480449716” or 48044971 6 or 480449 716 or 1229194 11 9 or “1229194119” or “122919411 9” or 1229194 119).rn,nm.
31 or 2
43 use ppez
5exp *edoxaban/
6(Edoxaban* or Lixiana* or Savaysa* or DU 176* or DU176*).ti,ab,kw.
75 or 6
87 use oemezd
94 or 8
10exp animals/
11exp animal experimentation/ or exp animal experiment/
12exp models animal/
13nonhuman/
14exp vertebrate/ or exp vertebrates/
15animal.po.
16or/10–15
17exp humans/
18exp human experimentation/ or exp human experiment/
19human.po.
20or/17–19
2116 not 20
229 not 21
2322 not conference abstract.pt.
24remove duplicates from 23
OTHER DATABASES
PubMedSame MeSH, keywords, limits, and study types used as per MEDLINE search, with appropriate syntax used.
Trial registries (Clinicaltrials.gov and others)Same keywords, limits used as per MEDLINE search.

Grey Literature

Dates for Search:October 10, 2016.
Keywords:Drug name, Indication
Limits:No language or date limits used

Relevant websites from the following sections of the CADTH grey literature checklist, “Grey matters: a practical tool for evidence-based searching” (http://www.cadth.ca/en/resources/finding-evidence-is/grey-matters) were searched:

  • Health Technology Assessment Agencies
  • Health Economics
  • Clinical Practice Guidelines
  • Drug and Device Regulatory Approvals
  • Advisories and Warnings
  • Drug Class Reviews
  • Databases (free)
  • Internet Search.
Copyright © CADTH 2017.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK475934

Views

  • PubReader
  • Print View
  • Cite this Page

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...